DiviDrip · LXEO

LXEO — Lexeo Therapeutics, Inc.

LXEO is Lexeo Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $4.84. Market cap: $397M. Capital Quality Rank: 23/100 — Capital destroyer.

Stock snapshot

Price$4.84
Market cap$397M
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)23 / 100 · Capital destroyer
ROIC (TTM)-19.5%
Shareholder buyback yield-30.00%
Altman Z-score zoneSafe

About LXEO

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Listed2023Employees59HQNew York, NYSectorHealthcareWebsitelexeotx.com

Related non-dividend companies

Other non-dividend stocks investors research alongside LXEO. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is LXEO's current stock price?

LXEO (Lexeo Therapeutics, Inc.) is currently trading at $4.84.

Does LXEO pay a dividend?

LXEO (Lexeo Therapeutics, Inc.) does not currently pay a regular dividend.

What is LXEO's Capital Quality Rank?

LXEO has a Capital Quality Rank of 23/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track LXEO in DiviDrip

Add LXEO to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow